Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2603_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
63 Мб
Скачать
10.3 · Diabetic Syndromes
https://t.me/medicina_free
411
10
Wolfram Syndrome (DIDMOAD)
Wolfram syndrome (WS) is a rare disease characterized by d iabetes i nsipidus, d iabetes m ellitus, o ptic a trophy, and sen- sorineural d eafness, making the acronym DIDMOAD.
WS has an autosomal recessive mode of inheritance, and it is caused by mutation in chromosome 4. Incidence of WS is estimated to be 1in 100,000 live births.
Diagnostic and key features of DIDMOAD include:
Ophthalmologic Clinical Findings
Bilateral progressive optic atrophy (98 % of cases) ( diagnostic criterion )
Auditory Clinical Findings
Bilateral sensorineural hearing loss is found in up to 12 % of cases ( diagnostic criterion ).
Metabolic and General Clinical Findings
5 Diabetes insipidus (35 % of cases) ( diagnostic criterion ) 5 DM (99 % of cases) ( diagnostic criterion ) 5 Hypogonadism (occasionally)
Renal Clinical Findings
5 Dilatation of the urinary tract with unknown cause
( diagnostic criterion )
5 Testicular atrophy (occasionally)
Neurological Clinical Findings
5 Ataxia due to cerebellar atrophy. 5 Short-term memory loss and dementia. 5  e mean age at death is 30 years, most commonly due
to brain stem atrophy and central respiratory failure.
5 Dysmorphic facial features, with large ears ( diagnostic
criterion )
5 Generalized hypertrichosis, with coarse head hair 5 Genital (phallic) enlargement ( diagnostic criterion ) 5 Premature dentition
Renal Clinical Findings
5 Bilateral renal enlargement with medullary sponge
kidney may be found. Medullary sponge kidney is a
congenital disease characterized by dilatation of the
collecting tubules in one or more renal papillae, a ecting
one or both kidneys.  ere is a high incidence of renal
calculi formation in medullary sponge kidney, with
hypercalciuria found in up to 50 % of patients. Gross
hematuria can be found in 10–20 % of patients.
5 Nephrocalcinosis.
Dermatological Clinical Findings
Typically, there are areas of hyperpigmentation and papillary hypertrophy on the neck and  exor creases (acanthosis nigricans).
Signs on IVU
Sponge kidney is diagnosed by the presence of typical cystic collection of contrast material in the collecting ducts in a form of “bouquet of fl owers or paintbrush appearance” (
. Fig. 10.3.3 ).
Signs on Brain MRI
5 Generalized brain atrophy, especially in the
cerebellum, medulla, and pons.
5 Loss of the posterior pituitary signal. 5 Atrophy of the optic nerves, tracts, and radiations. 5 Patchy areas of white matter demyelination may
be seen occasionally.
Rabson–Mendenhall Syndrome
Rabson–Mendenhall syndrome (RMS) is a rare genetic dis­ease with various somatic abnormalities, characterized by noninsulin-dependent DM due to severe insulin resistance, caused by insulin receptors mutation.  e disease has an autosomal recessive mode of inheritance.
Diagnostic and key features of RMS include:
Metabolic and General Clinical Findings
5 Noninsulin-dependent DM, postprandial hypoglycemia,
and hyperinsulinemia ( diagnostic criterion )
. Fig. 10.3.3 Intravenous urography radiograph of a patient
with sponge kidney shows the classical collecting duct paintbrush appearance ( arrowheads )
412
https://t.me/medicina_free
Chapter 10 · Diabetology
10
Further Reading
Barrett TG.Mitochondrial diabetes, DIDMOAD and other
inherited diabetes syndromes. Best Prac Res Clin Endocrinol Metab. 2001;15(3):325–43.
Benso C, etal.  ree new cases of Alström syndrome. Graefe’s
Arch Clin Exp Opthalmol. 2002;240:622–7.
Bin-Abbas B, et al. Wolcott-Rallison syndrome: clinical,
radiological, and histological  ndings in a Saudi child. Ann Saudi Med. 2001;21(1–2):73–4.
Cohen Jr MM.Syndromology: an updated conceptual over-
view. V.Aspects of aneuploidy. Int J Oral Maxillofac Surg. 1998;18:333–8.
Dippell J, etal. Early sonographic aspects of kidney morphol-
ogy in Bardet-Biedl syndrome. Pediatr Nephrol. 1998;12:559–63.
Donohue WL, etal. Leprechaunism. A Euphuism for a rare
familial disorder. J Pediatr. 1954;45(5):505–18.
Fralick RA, etal. Early diagnosis of Bardet-Biedl syndrome.
Pediatr Nephrol. 1990;4:264–5.
Galluzzi P, etal. MRI of Wolfram syndrome (DIDMOAD).
Neuroradiology. 1999;41:729–31.
Genis D, et al. Wolfram syndrome: a neuropathological
study. Acta Neuropathol. 1997;93:426–9.
Gupta S, etal. Medullary sponge kidney. Indian J Pediatr.
2002;69(12):1091–2.
Harris AM, etal. Rabson-Mendenhall syndrome: medullary
sponge kidney, a new component. Pediatr Nephrol. 2007;22:2141–4.
Hatori M, etal. Multiple epiphyseal dysplasia– report of two
families. Arch Orthop Trauma Surg. 2000;120:372–5.
Makaryus AN, etal. A rare case of Alström syndrome pre-
senting with rapidly progressing severe dilated cardiomy­opathy diagnosed by echocardiography. J Am Soc Echocardiogr. 2003;16:194–6.
Miller J, etal. Neurocognitive  ndings in Prader-Willi syn-
drome and early-onset morbid obesity. J Pediatr. 2006;149:192–8.
Morgan J, etal. US, CT, and MRI imaging of hepatic masses
in Alström syndrome: a case report. Clin Imaging. 2008;32:393–5.
Papavramidis ST, et al. Prader-Willi syndrome-associated
obesity treated by biliopancreatic diversion with duodenal switch. Case report and literature review. J Pediatr Surg. 2006;41:1153–8.
Parveen BA, et al. Rabson-Mendenhall syndrome. Int J
Dermatol. 2008;47:839–41.
Rubin EL, etal. Cystic disease of the renal pyramids (‘sponge
kidney’). J Fac Radiol. 1959;10(3):134–7.
Sebik A, etal.  e orthopaedic aspects of multiple epiphyseal
dysplasia. Int Orthopaed (SICOT). 1998;22:417–21.
Shannon P, etal. Evidence of widespread axonal pathology in
Wolfram syndrome. Acta Neuropathol. 1999;98:304–8.
Stöß H, etal. Wolcott-Rallison syndrome: diabetes mellitus
and spondyloepiphyseal dysplasia. Eur J Pediatr. 1982;138:120–9.
Summitt RL, etal. Leprechaunism (Donohue’s syndrome): a
case report. J Pediatr. 1969;74(4):601–10.
Tekgül S, etal. Urological manifestations of the observation
in 14 patients. J Urol. 1999;161:616–7.
Tobin JL, etal. Bardet-Biedl syndrome: beyond the cilum.
Pediatr Radiol. 2007;22:926–36.
Urben SL, etal. Otolaryngologic features of Laurence-Moon-
Bardet-Biedl syndrome. Otolaryngol Head Neck Surg. 1999;120:571–4.
Verri A, etal. A case of Wolfram syndrome: neurological fea-
tures. Ital J Neurol Sci. 1982;4:351–3.
10.4 Diabetes Insipidus
Diabetes insipidus (DI) is a disease characterized by increased
frequency of urination (polyuria), with increased  uid intake
(polydipsia) secondary to inappropriate secretion of the
antidiuretic hormone (ADH) vasopressin from the posterior
pituitary gland.
ADH is secreted by the supraoptic and paraventricular
hypothalamic nuclei and stored in the terminals within the
posterior pituitary. Neurohypophysis is a term used to describe
the posterior pituitary, the infundibular stalk, and the
supraoptic and paraventricular hypothalamic nuclei. ADH
regulates  uid and electrolytes balance within the body by
promoting water reabsorption in the distal tubules in the
kidneys.
According to its origin, DI is classi ed into three types:
5 Neurogenic DI can be idiopathic (50 %), genetic (5 %),
secondary to tumor (e.g., craniopharyngioma), or secondary to in ammatory reactions (e.g., Langerhans cell histiocytosis).
5 Nephrogenic DI can be due to primary renal disease or
secondary to chronic renal failure or hypercalcemia.
5 Dipsogenic DI arises due to compulsive polydipsia or due
to hypothalamic disorders a ecting the thirst center.
DI has a prevalence of 1:25,000 of the population. Patients typically present with polyuria and polydipsia.  e polyuria is not reduced by cessation of  uid intake. Signs of dehydration, such as dry skin, hypotension, and tachycardia, are o en found. Serum electrolyte investigations show high plasma osmolarity, hypernatremia, hypokalemia, hyperglycemia, and hypercalcemia.
 e most common hypothalamic tumors associated with DI are metastases, germinoma, and craniopharyngioma. Craniopharyngioma is a benign, slow-growing tumor that arises from the remnant of Rathke ’ s pouch (craniopharyngeal duct). It can occur in children between 6 and 15 years of age and adults between 50 and 60 years of age. Up to 50 % of suprasellar lesions in children are craniopharyngiomas. Patients usually present with visual disturbance (bitemporal quadrantanopia), headache, and hypothalamic dysfunction.
As previously mentioned, the neurohypophysis is com­posed of the posterior pituitary lobe, the infundibular stalk, and the median eminence of the hypothalamus.  e normal posterior pituitary shows high signal intensity on native T1W images (
. Fig. 10.4.1 ). It is thought that this
10.4 · Diabetes Insipidus
https://t.me/medicina_free
. Fig. 10.4.1 Sagittal nonenhanced T1W MRI of the sella shows the
physiological bright signal of the posterior hypophysis ( arrowhead )
413
5 Craniopharyngioma : on CT, the main bulk of the
lesion is located in the suprasellar region and has
cystic (90 %) and solid components with rim-like or
nodular calcifi cations in up to 80 % of cases
(
. Fig. 10.4.3 ). The solid component enhances after
contrast administration. On MRI, the lesion has high
T1 signal and high/low T2 signal according to the fat
and thick protinaceous (motor oil) consistency
within the lesion. The solid component enhances
after contrast administration.
5 Langerhans cell histiocytosis : there is typical
enlargement of the central part of the
infundibulum (>2.5 mm) when Langerhans cell
histiocytosis is the main cause of DI (
5 Bilateral, symmetrical brain calcifications within
the basal ganglia and the subcortical area have
been reported as unusual manifestations of
DI. These findings are best evaluated on CT.
5 Ectopic posterior pituitary is seen as a bright spot,
typically located in the hypothalamic eminence
(
. Fig. 10.4.5 ) .
. Fig. 10.4.4 ).
10
bright spot is due to the macrogranules composed of the ADH neurophysin complex. Ectopic posterior pituitary is a condition where the posterior pituitary bright signal spot on MR imaging is not located in the posterior pituitary lobe but is typically seen in the median hypothalamic emi­nence.
 e anterior pituitary gland ( adenohypophysis ) normally
shows the same signal characteristic as the rest of the brain on T1W images. However, the adenohypophysis can show a bright signal on native T1W images during the  rst 2 years of life, due to secretory activity, or in preterm babies during the  rst 2 months of life.  e bright signal of the adenohypophy­sis is best demonstrated with the magnetization transfer MR sequence.
Signs on Brain MRI (Done in Patients with Suspected Neurogenic DI)
5 Genetic cause : there is loss of the typical posterior
pituitary hyperintensity signal on T1W contrast-enhanced images ( However, the neurohypophysis bright spot can be absent in 10–20 % of normal individuals.
. Fig. 10.4.2 ).
. Fig. 10.4.2 Sagittal nonenhanced T1W MR illustration of
the sella shows loss of the physiological posterior pituitary bright spot, which is a characteristic fi nding in idiopathic or genetic diabetes insipidus
414
https://t.me/medicina_free
Chapter 10 · Diabetology
a
. Fig. 10.4.4 Sagittal nonenhanced T1W MR illustration of
the sella shows thickened infundibulum due to Langerhans cell
histiocytosis ( arrowhead )
10
b
. Fig. 10.4.3 Axial nonenhanced brain CT ( a ) and sagittal
contrast-enhanced T1W MRI of the sella show craniopharyngioma in a 40-year-old patient. In ( b ), the main bulk of the lesion is located in the suprasellar area, with infi ltration of the sella turcica and the sphenoid sinus. The lesion is mostly solid, with anterior cystic component located in the inferior frontal region ( arrowhead ). In ( a ), a calcifi ed rim that surrounds the lesion is nicely illustrated
10.5 · Obesity, Gastric Banding, and Liposuction
https://t.me/medicina_free
a
415
Mavrakis AN, etal. Diabetes insipidus with de cient thirst:
report of a patient and review of the literature. Am J Kidney Dis. 2008;51(5):851–9.
Mitchell LA, etal. Ectopic posterior pituitary lobe and peri-
ventricular heterotopia: cerebral malformation with the same underlying mechanism. AJNR Am J Neuroradiol. 2002;23:1475–81.
Saeki N, etal. MRI of ectopic posterior pituitary bright spot
with large adenomas : appearances and relationship to transient postoperative diabetes insipidus. Neuroradiology. 2003;45:713–6.
Schmitt S, etal. Pituitary stalk thickening with diabetes insip-
idus preceding typical manifestations of Langerhans cell histiocytosis in children. Eur J Pediatr. 1993;152:399–401.
10.5 Obesity, Gastric Banding,
and Liposuction
10
b
. Fig. 10.4.5 Sagittal ( a ) and axial ( b ) T1W MRI shows an
ectopic high signal intensity spot located at the proximal part of the infundibulum (ectopic posterior pituitary)
Obesity is a disease characterized by an increase in the size and number of fat cells. Fat cell size di ers from region to region within the body, and the number of fat cells may increase three- to  vefold during adolescence. Overweight is de ned as a body weight of 101–120 % of the ideal, while obesity is de ned as fat accumulation >120 % of the ideal.
Obesity is de ned by the World Health Organization
(WHO) as the ratio of body mass to body height (kg/m 2 ), the so-called body mass index (BMI). A BMI of 25–30kg/m 2 is considered “overweight,” >30 kg/m 2 is de ned as “obesity,” and >40kg/m 2 is de ned as “morbid obesity.” BMI is used as a marker for estimating the risks for diseases such as diabetes mellitus and cardiovascular diseases. Women usually have gynecoid fat distribution around the hips, while men have android fat distribution where adiposity is predominantly central.
Patients with obesity su er from many systemic diseases such as diabetes mellitus and insulin insensitivity, cardiovas­cular diseases, obstructive sleep apnea, osteoarthritis, venous stasis and varicosities, and gout.
 ere are di erent causes of obesity. Apart from a seden­tary lifestyle and high-carbohydrate food intake, hormonal, syndromic/pathologic, and drug-induced lipomatoses are other common causes of obesity. Each cause induces obesity by a di erent mechanism.
Further Reading
Al-Kandari SR, etal. Intracranial calci cation in central dia-
betes insipidus. Pediatr Radiol. 2008;38:101–3.
Hadjizacharia P, etal. Acute diabetes insipidus in severe head
injury: a prospective study. J Am Coll Surg. 2008;207:477–84.
Jane Jr JA, etal. Neurogenic diabetes insipidus. Pituitary.
2006;9:327–9.
Kassebaum N, etal. Diabetes insipidus associated with pro-
pofol anesthesia. J Clin Anesth. 2008;20:466–8.
Maghnie M, etal. Central diabetes insipidus in children and
young adults. N Eng J Med. 2000;343:998–1007.
Maria IA.MRI of the hypothalamic-pituitary axis in chil-
dren. Pediatr Radiol. 2005;35:1045–55.
Hormonal Obesity
5 Hypothalamic obesity : obesity that arises a er
paraventricular ventromedial hypothalamic injury, causing hyperphagia due to loss of the serum leptin level sensitization.
5 Cushings syndrome : obesity is a cardinal sign of
Cushing’s syndrome. Patients classically present with truncal (android) obesity.
5 Hypothyroidism : obesity in hypothyroidism is mainly due
to a slow metabolic rate.  e weight gain is o en modest, without marked obesity.
416
https://t.me/medicina_free
Chapter 10 · Diabetology
10
5 Polycystic ovary disease : up to 50 % of patients with
polycystic ovary disease are overweight with insulin resistance.
5 Growth hormone de ciency : growth hormone de ciency
causes a reduction in lean body mass and an increase in fat body mass.
Syndromic/Pathologic Obesity
5 Lipoma is de ned as the localized, encapsulated
accumulation of fat. It can be single or multiple and can be seen in any part of the body (. Fig. 10.5.1 ). Multiple lipomas can be seen in Ma ucci syndrome and neuro bromatosis type 1 ( von Recklinghausen disease ).
5 Lipomatosis is a condition characterized by proliferation
of nonencapsulated fat cells (. Fig. 10.5.2 ).
5 Liposarcoma is a rare malignant tumor characterized by
neoplastic proliferation of fat cells (. Fig. 10.5.3 ).
5 Lipodystrophy is a condition characterized by loss of body
fat in one or more areas. It can be genetic or acquired (e.g., HIV drug-induced lipodystrophy).
5 Binge - eating disorder is a psychiatric disorder,
characterized by uncontrolled episodes of eating, usually in the evening.
5 Night - eating syndrome is a psychiatric disorder,
characterized by consumption of at least 25 % of daily energy between the evening meal and the next morning. Patients o en awake at night to eat, three or more times per week.
5 Dercums disease ( lipomatosis dolorosa ) is a rare disease,
characterized by painful subcutaneous fatty tissue with in ammatory characteristics. Patients are typically young obese women 25–40 years of age, presenting with vague pain that can be focal or generalized. Many patients live with this disease while being unaware of it, either
because the disease sometimes shows mild symptoms or because patients receive a wrong diagnosis.
Lipomatosis dolorosa can be mistaken for  bromyalgia rheumatica. Unlike  bromyalgia rheumatica, the pain in lipo­matosis dolorosa increases with body weight gain.  e pain o en has insidious onset and progresses with time.  e pain in lipomatosis dolorosa is chronic (>3months duration), aching, stabbing, or burning and usually symmetrical (. Fig. 10.5.4 ). However, localized pain may be seen in the upper limbs or around the knee.  e face and hands are typically not involved.
 e pain characteristically arises from the subcutaneous fat.  e pain may worsen on any light touch or pressure (allo­dynia), wearing tight clothes, or taking a shower. Also, the pain is temperature and humidity dependent and usually reduces when the weather is hot and dry. Hot baths may reduce the pain but only temporarily.  e pain is thought to be caused by
. Fig. 10.5.2 Axial abdominal postcontrast CT shows retroperitoneal
lipomatosis, with increased fat content of the retroperitoneum pushing the kidneys anteriorly in a bilateral fashion ( arrowheads )
. Fig. 10.5.1 Axial nonenhanced chest CT shows left chest wall
lipoma, seen as a typically well-circumscribed mass with fat attenuation ( arrowhead )
. Fig. 10.5.3 Axial abdominal postcontrast CT shows severe
abdominal fatty proliferation that pushes the left kidney and the intestines to the left abdominal cavity region ( arrowhead ) due to proliferating retroperitoneal liposarcoma
10.5 · Obesity, Gastric Banding, and Liposuction
https://t.me/medicina_free
417
10
fat masses pressing upon the nerve root endings or by releasing cytokines that induce pain (e.g., tumor necrosis factor-α).
 ree types of lipomatosis dolorosa are described: type 1 ( juxta - articular ), with painful subcutaneous folds around the knees or the hips; type 2 ( di use ), which a ects the whole body symmetrically; and type 3 ( nodular ), characterized by intense pain around lipomas.
5 We b er Christian disease ( WCS ) is a disease characterized
by painful subcutaneous nodules found mainly on the trunk and the extremities, with constitutional symptoms like fever, fatigue, polymyalgia, and arthralgia.  e subcutaneous nodules are composed of lobular panniculitis (subcutaneous tissue in ammation). When the panniculitis is systemic, WCS can be fatal in up to 10 % of patients. Patients commonly show elevated erythrocyte sedimentation rate and C-reactive protein levels.
5 Madelungs disease ( benign symmetric
lipomatosis / LaunoisBensaude syndrome ) is a rare condition, characterized by massive symmetric deposits of nonencapsulated adipose tissue in the head, the neck, and the upper trunk.
Madelung’s disease (MD) is typically seen in middle-aged males of Mediterranean origin with a history of excessive alcohol consumption (90 % of cases). Patients with MD typi­cally consume more than 80g of alcohol per day for more than 10 years. MD is considered a “sight diagnosis” because of the typical patterns of fat distribution in the head and neck region. Lipomatosis is typically seen accumulating in both parotid regions (hamster cheek appearance), cervical region (horse collar appearance), and the posterior neck region (bu alo hump appearance) (. Fig. 10.5.5 ).  e disease is divided into two types: type 1 MD is characterized by sym- metric body lipomatosis that gives the patient a “pseudo­athletic” appearance (. Fig. 10.5.5 ). Type 2 MD is characterized by di use lipomatosis that gives the patient a generalized obese appearance.
Sensory, motor, or autonomic polyneuropathy is seen in up to 85 % of patients with MD.Rarely, the tongue or the mediastinum is involved in lipomatosis, resulting in dyspha­gia and dyspnea.
5 Metabolic syndrome ( syndrome X ) is de ned by the WHO
as the presence of impaired glucose regulation or
. Fig. 10.5.4 An illustration
demonstrates the typical pain distribution in dercum dolorosa
418
https://t.me/medicina_free
Chapter 10 · Diabetology
10
diabetes, with two of the following risk factors: hypertension, dyslipidemia, central obesity, and microalbuminuria.  ere is a strong association between the development of metabolic syndrome and increase in visceral adipose tissue (VAT).
5 Fröhlich syndrome is a rare hypothalamic disorder,
characterized by obesity, stunned growth, and genital hypoplasia.
5 Obesity hypoventilation ( Pickwickian ) syndrome is a
disease characterized by the triad of morbid obesity,
a
hypoventilation, and irresistible hypersomnolence (drowsiness). Hypoventilation in Pickwickian syndrome is de ned clinically by an arterial blood gas as a PaCO 2 > 45 and/or a PO 2 < 55in the presence of morbid obesity.  is hypoventilation is attributed to obstructive sleep apnea in these patients and by the ventilation/ perfusion mismatch that results from the irregular shallow breathing with or without compression by a thick chest wall.
b
c
. Fig. 10.5.5 An illustration demonstrates the typical clinical signs of Madelung’s disease: ( a ) hamster cheeks appearance, ( b ) horse collar
appearance, ( c ) buff alo hump appearance, and ( d ) pseudo-athletic appearance
d
10.5 · Obesity, Gastric Banding, and Liposuction
https://t.me/medicina_free
419
10
Drug-Induced Obesity
5 Glucocorticoids use : glucocorticoids cause fat
accumulation in the body in a similar fashion to people with Cushing’s syndrome. Glucocorticoid obesity is seen in patients with chronic prednisolone intake >10mg/day or its equivalent.
5 Cessation of smoking : patients who quit smoking can gain
up to 4–5kg on average, and it is partly mediated by nicotine withdrawal.
Evaluation of Fat Within the Body
 ere are several techniques used to estimate body fat. Anthropometry is a technique used to estimate BMI by mea­suring waist circumference and skinfold thickness. BMI is a good indicator of obesity, but it provides indirect measure­ment of body fat and is unable to di erentiate lean body mass from body fat.  e inability of BMI to discriminate lean body mass from fat body mass leads to de ning lean, muscular individuals as obese.
The metabolism of adipocytes varies with fat sites. Fat deposits in the abdomen and flank are more metabolically active than fat deposits in the buttocks or thighs. Upper­body obesity is more associated with hypertension, glu­cose intolerance, and serum cholesterol levels than is lower-body obesity. Recent research emphasizes the high risks of cardiovascular diseases and metabolic abnormali­ties associated with increased intra-abdominal VAT.VAT is defined as the fatty tissue that accumulates beneath the abdominal muscle wall and surrounding the abdominal viscera. VAT mass is pathologically more important than subcutaneous fat thickness over the trunk. Also, visceral fat is a major determinant of whole body insulin resis­tance.
Adipose tissue is a specialized loose connective tissue that is laden with adipocytes. It works as a source of energy, ther­mal insulation (e.g., brown fat), and as a mechanical cushion in mammals. A 70-kg man normally has 15kg of adipose tissue, representing 21 % of body mass. In contrast, fat is a term used to describe the chemical lipid component in the form of triglycerides. It can be found within adipocytes or in pathological conditions like fatty liver. Modern methods use ultrasound, CT, and MRI as useful and accurate tools for VAT quanti cation.
Quantitative Assessment of Visceral Fat by US
Ultrasound can be used as a fast and easy method to quantify visceral and subcutaneous fat. Although it is not as standard as CT quanti cation, it is reported by many investigators to be an accurate method to quantify the abdominal wall fat thickness and preperitoneal fat thickness.
Quantitative Assessment of Visceral Fat by CT and MRI
An axial body section is taken at the level of the navel or (L4/ L5), and assessment is done via a computer so ware program to calculate the percentage of visceral fat distribution
. Fig. 10.5.6 An axial CT section obtained at the level of L4/L5
vertebra
(. Figs. 10.5.6 and 10.5.7 ). Excess visceral fat typically sepa- rates the intra-abdominal structures.  e drawbacks of the CT method are the use of radiation and the limited gantry diameter to patients less than 70cm wide (the standard CT gantry diameter). MRI, on the other hand, is radiation-free but more expensive in its use as a regular monitoring method.  e MRI method uses the same procedures as the CT method of quanti cation.
Gastric Banding
Gastric banding is a widely performed surgical procedure as a surgical therapy for morbid obesity.  e procedure consists of placing a silicon band around the upper part of the stom­ach to create a small gastric pouch that works as a stomach (neostomach).  e pouch is connected to the rest of the stomach via a narrow stoma.  e silicon band contains an adjustable inner balloon that can be in ated with air or  uid up to 5cm 3 , and it is connected to a reservoir that is typically sutured to the anterior rectus sheath.  e stoma width nor­mally should be within 3–4mm.
 e gastric banding procedure controls obesity by restricting food administration to the stomach into a small gastric pouch and narrow stoma, which creates early satiety when the pouch is full. Although gastric banding is a relatively safe procedure, several complications may arise later in up to 35 % of cases. Additional surgery may be required in up to 11 % of cases.
Early complications of gastric banding include esophageal perforation (0.5 % of cases), dysphagia (14 % of cases), gastroesophageal re ux disease, and early slippage of the band (1 % of cases). Late complications include eccentric pouch dilatation (25 %), slippage of the band (24 %), intragastric band migration, and gastric necrosis (<0.3 %). Patients with diabetes show early gastric dilatation due to diabetic gastroparesis.
420
https://t.me/medicina_free
Chapter 10 · Diabetology
a
b
10
c
. Fig. 10.5.7 Computer-generated histogram segmentation of the same CT section as (. Fig. 10.5.6 ) done by using image analysis software
(Image J). The image in ( a ) refl ects fat density (represented in white ), and the other nonfatty tissues are removed (represented in black ). Image ( b ) represents total body volume, image ( c ) represents subcutaneous tissue volume (in back after inversion of the original white color ), and image ( d ) represents VAT volume (in black ). The volume of VAT or subcutaneous tissue in this image is gained in cm 2 . The volume must be multiplied by the slice thickness of the original image to get the fat volume in cm
Fluoroscopic barium meal examination is performed to detect abnormalities and complications of gastric banding. Initially, a scout supine abdominal image is taken to identify the place of the band and the reservoir. Water-soluble con­trast media is initially administered in the early stages to
d
3
con rm the absence of leakage.  e normal images should reveal a small upper gastric pouch, a narrow stoma extend­ing through the gastric band, and opaci cation of the rest of the stomach (. Fig. 10.5.8 ). CT can be performed a er the  uoroscopic examination to detect other abnormalities.